← Back to headlines
Replimune Seeks Third FDA Approval Attempt After Executive Departure
Replimune is pursuing a third attempt at FDA approval following the departure of Makary.
29 May, 12:19 — 29 May, 12:19
Sources
Showing 1 of 1 sources
Replimune is pursuing a third attempt at FDA approval following the departure of Makary.
